Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Amphastar Pharmaceuticals (AMPH) Short-Term Debt repayments (2021 - 2023)

Amphastar Pharmaceuticals (AMPH) has 4 years of Short-Term Debt repayments data on record, last reported at $125.0 million in Q2 2023.

  • For Q2 2023, Short-Term Debt repayments changed N/A year-over-year to $125.0 million; the TTM value through Jun 2023 reached $125.4 million, changed N/A, while the annual FY2021 figure was $1.2 million, N/A changed from the prior year.
  • Short-Term Debt repayments reached $125.0 million in Q2 2023 per AMPH's latest filing, up from $387000.0 in the prior quarter.
  • Across five years, Short-Term Debt repayments topped out at $125.0 million in Q2 2023 and bottomed at $387000.0 in Q3 2021.